FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025172847> ?p ?o ?g. }

• W3025172847 endingPage "667" @default.
• W3025172847 startingPage "659" @default.
• W3025172847 abstract "The antimalarial drug hydroxychloroquine (HCQ) has long been used as a disease-modifying antirheumatic drug for the treatment of several inflammatory rheumatic diseases. Over the last three decades, various studies have shown that HCQ also plays a role in the regulation of glucose homeostasis. Although the mechanisms of action underlying the glucose-lowering properties of HCQ are still not entirely clear, evidence suggests that this drug may exert multifaceted effects on glucose regulation, including improvement of insulin sensitivity, increase of insulin secretion, reduction of hepatic insulin clearance, and reduction of systemic inflammation. Preliminary studies have shown the safety and efficacy of HCQ (at a dose ranging from 400 to 600 mg/day) in patients with type 2 diabetes over a short-term period. In 2014, HCQ has been approved in India as an add-on hypoglycemic agent for patients with uncontrolled type 2 diabetes. However, large randomized controlled trials are needed to establish the safety and efficacy profile of HCQ in patients with type 2 diabetes over a long-term period. With regard to the COVID-19 pandemic, several medications (including HCQ) have been used as off-label drugs because of the lack of proven effective therapies. However, emerging evidence shows limited benefit from HCQ use in COVID-19 in general. The aim of this manuscript is to comprehensively summarize the current knowledge on the antihyperglycemic properties of HCQ and to critically evaluate the potential risks and benefits related to HCQ use in patients with diabetes, even in light of the current pandemic scenario.抗疟药羟基氯喹(HCQ)长期以来一直作为一种缓解症状的药物, 用于多种炎症性风湿病的治疗。在过去的三十年里, 各种研究表明HCQ在调节葡萄糖稳态方面也起着作用。虽然HCQ的降糖作用机制尚不完全清楚, 但有证据表明该药可能具有多方面的血糖调节作用, 包括改善胰岛素敏感性, 增加胰岛素分泌, 降低肝脏胰岛素清除率和减轻全身炎症。初步研究表明, HCQ(每天剂量从400 - 600毫克)对2型糖尿病患者短期内是安全和有效的。2014年, HCQ在印度被批准作为未受控制的2型糖尿病患者的附加降糖药。然而, 仍然需要大型随机对照试验来确定HCQ在2型糖尿病患者中的长期安全性和有效性。在新冠肺炎大流行期间, 由于缺乏被证明有效的治疗方法, 几种药物(包括HCQ)已在超适应症应用。可是, 新出现的证据显示, 总的来说新冠肺炎使用HCQ的益处是有限的。本文献旨在当前新冠大流行情况下, 全面总结目前关于HCQ降血糖特性的知识, 并严格评估与HCQ在糖尿病患者中使用相关的潜在风险和好处。." @default.
• W3025172847 created "2020-05-21" @default.
• W3025172847 creator A5013101960 @default.
• W3025172847 creator A5035428843 @default.
• W3025172847 creator A5059966253 @default.
• W3025172847 date "2020-06-11" @default.
• W3025172847 modified "2023-09-27" @default.
• W3025172847 title "Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of <scp>COVID</scp> ‐19 pandemic" @default.
• W3025172847 cites W1520164838 @default.
• W3025172847 cites W1971893269 @default.
• W3025172847 cites W1976578543 @default.
• W3025172847 cites W1977202165 @default.
• W3025172847 cites W1982112254 @default.
• W3025172847 cites W1995468535 @default.
• W3025172847 cites W2010378610 @default.
• W3025172847 cites W2023280567 @default.
• W3025172847 cites W2031331204 @default.
• W3025172847 cites W2046995007 @default.
• W3025172847 cites W2049583719 @default.
• W3025172847 cites W2050769289 @default.
• W3025172847 cites W2063544030 @default.
• W3025172847 cites W2067075939 @default.
• W3025172847 cites W2076310317 @default.
• W3025172847 cites W2085633034 @default.
• W3025172847 cites W2085667526 @default.
• W3025172847 cites W2094024942 @default.
• W3025172847 cites W2100295295 @default.
• W3025172847 cites W2100967823 @default.
• W3025172847 cites W2103025454 @default.
• W3025172847 cites W2111162895 @default.
• W3025172847 cites W2111220434 @default.
• W3025172847 cites W21121700 @default.
• W3025172847 cites W2116369874 @default.
• W3025172847 cites W2150367899 @default.
• W3025172847 cites W2164795678 @default.
• W3025172847 cites W2176451316 @default.
• W3025172847 cites W2179933935 @default.
• W3025172847 cites W2205085377 @default.
• W3025172847 cites W2207089259 @default.
• W3025172847 cites W2302013022 @default.
• W3025172847 cites W2318735764 @default.
• W3025172847 cites W2460357111 @default.
• W3025172847 cites W2566820606 @default.
• W3025172847 cites W2610341885 @default.
• W3025172847 cites W2612702080 @default.
• W3025172847 cites W2617680249 @default.
• W3025172847 cites W2619136524 @default.
• W3025172847 cites W2738187814 @default.
• W3025172847 cites W2802211483 @default.
• W3025172847 cites W2904890094 @default.
• W3025172847 cites W2908208572 @default.
• W3025172847 cites W2911759075 @default.
• W3025172847 cites W2937993724 @default.
• W3025172847 cites W2941278729 @default.
• W3025172847 cites W2948598127 @default.
• W3025172847 cites W2952794953 @default.
• W3025172847 cites W2972869264 @default.
• W3025172847 cites W2976815900 @default.
• W3025172847 cites W2978618786 @default.
• W3025172847 cites W2997829654 @default.
• W3025172847 cites W3004280078 @default.
• W3025172847 cites W3004709581 @default.
• W3025172847 cites W3008394013 @default.
• W3025172847 cites W3008928028 @default.
• W3025172847 cites W3009885589 @default.
• W3025172847 cites W3013125498 @default.
• W3025172847 cites W3013283620 @default.
• W3025172847 cites W3013365852 @default.
• W3025172847 cites W3013816672 @default.
• W3025172847 cites W3013883100 @default.
• W3025172847 cites W3014194455 @default.
• W3025172847 cites W3015347198 @default.
• W3025172847 cites W3015826819 @default.
• W3025172847 cites W3015989800 @default.
• W3025172847 cites W3016084006 @default.
• W3025172847 cites W3016370968 @default.
• W3025172847 cites W3019646457 @default.
• W3025172847 cites W3020317521 @default.
• W3025172847 cites W3021501395 @default.
• W3025172847 cites W3021685740 @default.
• W3025172847 cites W3021959078 @default.
• W3025172847 cites W3022358203 @default.
• W3025172847 cites W3022618603 @default.
• W3025172847 cites W3023250042 @default.
• W3025172847 cites W3023346879 @default.
• W3025172847 cites W3025172847 @default.
• W3025172847 cites W3035467903 @default.
• W3025172847 cites W4211193988 @default.
• W3025172847 cites W4301347913 @default.
• W3025172847 cites W4368222814 @default.
• W3025172847 cites W960848000 @default.
• W3025172847 cites W1935403436 @default.
• W3025172847 cites W3024057897 @default.
• W3025172847 doi "https://doi.org/10.1111/1753-0407.13053" @default.
• W3025172847 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7272905" @default.
• W3025172847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32401405" @default.
• W3025172847 hasPublicationYear "2020" @default.
• W3025172847 type Work @default.

• next